Synthesis and biological evaluation of (+/-)-cryptotanshinone and its simplified analogues as potent cdc25 inhibitors | |
Huang, WG; Jiang, YY; Li, Q; Li, J; Li, JY; Lu, W; Cai, JC | |
刊名 | Tetrahedron |
2005-02-14 | |
卷号 | 61期号:7页码:1863-1870 |
关键词 | Cdc25 inhibitor Cryptotanshinone Analogues Antitumor |
ISSN号 | 0040-4020 |
DOI | 10.1016/j.tet.2004.12.033 |
通讯作者 | Li, j() |
英文摘要 | (+/-)-cryptotanshinone and its simplified analogues were synthesized via smi2 promoted radical cyclization to construct the furan ring. analogues 18 and 26 were identified as effective inhibitors of dual specificity protein phosphatase cdc25b which is a key enzyme for cell cycle progression, and they also inhibited growth in a-549 human lung cancer cell line. (c) 2004 elsevier ltd. all rights reserved. |
WOS关键词 | SPECIFICITY PHOSPHATASE INHIBITORS ; HUMAN COLORECTAL-CARCINOMA ; CELL-CYCLE ARREST ; PROTEIN PHOSPHATASE ; SALVIA-MILTIORRHIZA ; TANSHINONE-IIA ; TYROSINE ; DYSIDIOLIDE ; QUINONES ; CRYPTOTANSHINONE |
WOS研究方向 | Chemistry |
WOS类目 | Chemistry, Organic |
语种 | 英语 |
出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
WOS记录号 | WOS:000226915200025 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2377399 |
专题 | 中国科学院大学 |
通讯作者 | Li, J |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, SIBS, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Grad Sch, Beijing, Peoples R China |
推荐引用方式 GB/T 7714 | Huang, WG,Jiang, YY,Li, Q,et al. Synthesis and biological evaluation of (+/-)-cryptotanshinone and its simplified analogues as potent cdc25 inhibitors[J]. Tetrahedron,2005,61(7):1863-1870. |
APA | Huang, WG.,Jiang, YY.,Li, Q.,Li, J.,Li, JY.,...&Cai, JC.(2005).Synthesis and biological evaluation of (+/-)-cryptotanshinone and its simplified analogues as potent cdc25 inhibitors.Tetrahedron,61(7),1863-1870. |
MLA | Huang, WG,et al."Synthesis and biological evaluation of (+/-)-cryptotanshinone and its simplified analogues as potent cdc25 inhibitors".Tetrahedron 61.7(2005):1863-1870. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论